FUNCTIONALIZED CONGENERS OF BIOACTIVE COMPOUNDS
生物活性化合物的功能化同系物
基本信息
- 批准号:3776296
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Recent work in our laboratory has demonstrated that certain drugs may be
attached to well-defined "carrier" molecules and still retain the ability
to bind to the receptor site and effect biological activity. This
synthetic strategy for the attachment of drugs to carriers is termed the
"functionalized congener" approach. The "carrier" molecule may be many
times larger than the parent drug; indeed there is practically no maximum
size limitation for a fully potent analog. Unlike the prodrug approach
or the immobilization of drugs for slow release, the "functionalized
congener" approach is designed to produce analogs for which no metabolic
cleavage step is necessary for activation. Moreover, the attachment of
the drug to a "carrier" such as a peptide may result in enhanced affinity
at an extracellular receptor site and an improvement in the
pharmacological profile of the parent drug.
Purine derivatives containing attached chains were developed as
functionalized congeners for adenosine receptors and for ATP receptors.
Reporter groups such as fluorescent dyes have been covalently attached
resulting in receptor probes of relatively high affinity. Sites for
chain derivatization on the structures of telenzepine (useful drugs in
treating stomach ulcers and as research tools for the brain), a selective
muscarinic antagonists, have been located. In a series of amino alkyl
derivatives, it was found that increasing the chain length enhances the
potency of the derivative as a muscarinic antagonist. By incorporation
of a phenyl isothio-cyanate group, chemically reactive affinity labels
for muscarinic receptors were developed. Other reporter groups included
in the telenzepine series include biotin, p-aminophenylacetyl (for
preparing radiotracers and photoaffinity labeling reagents), and
fluorescent dyes fluorescein and tetramethylrhodamine (for locating the
receptor sites microscopically and for binding assays that do not require
the use of radioisotopes).
我们实验室最近的研究表明,某些药物可能
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
K JACOBSON其他文献
K JACOBSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('K JACOBSON', 18)}}的其他基金
PROSTHETIC GROUPS FOR RADIOLABELING OF FUNCTIONALIZED DRUGS AND PEPTIDES
用于功能化药物和肽的放射性标记的辅基
- 批准号:
3776297 - 财政年份:
- 资助金额:
-- - 项目类别:














{{item.name}}会员




